Benedict Financial Advisors Inc Gilead Sciences, Inc. Transaction History

Benedict Financial Advisors Inc

  • $458 Million
  • Q3 2025

A detailed history of Benedict Financial Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 12,414 shares of GILD stock, worth $1.54 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
12,414
Previous 12,371 0.35%
Holding current value
$1.54 Million
Previous $1.37 Million 0.44%
% of portfolio
0.3%
Previous 0.32%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
BUY
$108.22 - $120.47 $4,653 - $5,180
43 Added 0.35%
12,414 $1.38 Million
Q2 2025

Aug 13, 2025
BUY
$96.91 - $113.0 $4,360 - $5,085
45 Added 0.37%
12,371 $1.37 Million
Q1 2025

May 07, 2025
SELL
$89.14 - $117.41 $6,418 - $8,453
-72 Reduced 0.58%
12,326 $1.38 Million
Q4 2024

Jan 28, 2025
BUY
$83.95 - $97.9 $4,449 - $5,188
53 Added 0.43%
12,398 $1.15 Million
Q3 2024

Oct 24, 2024
SELL
$66.59 - $83.99 $11,187 - $14,110
-168 Reduced 1.34%
12,345 $1.03 Million
Q2 2024

Jul 30, 2024
SELL
$63.15 - $72.88 $2,147 - $2,477
-34 Reduced 0.27%
12,513 $858,000
Q1 2024

Apr 25, 2024
BUY
$71.58 - $87.29 $1,431 - $1,745
20 Added 0.16%
12,547 $919,000
Q4 2023

Jan 29, 2024
BUY
$73.27 - $83.09 $4,835 - $5,483
66 Added 0.53%
12,527 $1.01 Million
Q3 2023

Oct 18, 2023
BUY
$73.94 - $80.67 $3,918 - $4,275
53 Added 0.43%
12,461 $933,000
Q2 2023

Aug 10, 2023
BUY
$76.01 - $86.7 $3,800 - $4,335
50 Added 0.4%
12,408 $956,000
Q1 2023

May 11, 2023
BUY
$77.31 - $88.08 $4,793 - $5,460
62 Added 0.5%
12,358 $1.03 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $124 - $178
-2 Reduced 0.02%
12,296 $1.06 Million
Q3 2022

Nov 07, 2022
SELL
$59.54 - $68.01 $105,862 - $120,921
-1,778 Reduced 12.63%
12,298 $759,000
Q2 2022

Jul 28, 2022
SELL
$57.72 - $65.01 $59,220 - $66,700
-1,026 Reduced 6.79%
14,076 $870,000
Q1 2022

May 03, 2022
SELL
$57.92 - $72.58 $133,389 - $167,151
-2,303 Reduced 13.23%
15,102 $898,000
Q4 2021

Feb 09, 2022
SELL
$64.88 - $73.64 $17,712 - $20,103
-273 Reduced 1.54%
17,405 $1.26 Million
Q3 2021

Oct 29, 2021
SELL
$67.69 - $73.03 $20,713 - $22,347
-306 Reduced 1.7%
17,678 $1.24 Million
Q2 2021

Aug 05, 2021
SELL
$63.47 - $69.35 $73,180 - $79,960
-1,153 Reduced 6.02%
17,984 $1.24 Million
Q1 2021

May 10, 2021
SELL
$60.0 - $68.46 $61,200 - $69,829
-1,020 Reduced 5.06%
19,137 $1.24 Million
Q4 2020

Feb 02, 2021
SELL
$56.65 - $64.55 $6,571 - $7,487
-116 Reduced 0.57%
20,157 $1.17 Million
Q3 2020

Nov 03, 2020
SELL
$62.1 - $78.08 $27,945 - $35,136
-450 Reduced 2.17%
20,273 $1.28 Million
Q2 2020

Jul 23, 2020
BUY
$72.34 - $84.0 $6,510 - $7,560
90 Added 0.44%
20,723 $1.59 Million
Q1 2020

Apr 21, 2020
SELL
$62.63 - $80.22 $153,881 - $197,100
-2,457 Reduced 10.64%
20,633 $1.54 Million
Q4 2019

Feb 04, 2020
SELL
$61.62 - $67.78 $139,877 - $153,860
-2,270 Reduced 8.95%
23,090 $1.5 Million
Q3 2019

Nov 04, 2019
SELL
$62.51 - $69.0 $7,813 - $8,625
-125 Reduced 0.49%
25,360 $1.61 Million
Q2 2019

Aug 01, 2019
SELL
$61.87 - $69.38 $10,641 - $11,933
-172 Reduced 0.67%
25,485 $1.72 Million
Q1 2019

May 01, 2019
SELL
$62.53 - $70.05 $23,948 - $26,829
-383 Reduced 1.47%
25,657 $1.67 Million
Q4 2018

Jan 30, 2019
BUY
$60.54 - $79.0 $17,496 - $22,831
289 Added 1.12%
26,040 $1.63 Million
Q3 2018

Nov 05, 2018
BUY
$71.28 - $78.92 $19,815 - $21,939
278 Added 1.09%
25,751 $1.99 Million
Q2 2018

Jul 24, 2018
BUY
$64.88 - $75.68 $43,664 - $50,932
673 Added 2.71%
25,473 $1.8 Million
Q1 2018

May 02, 2018
BUY
$72.84 - $88.8 $33,433 - $40,759
459 Added 1.89%
24,800 $1.87 Million
Q4 2017

Feb 05, 2018
BUY
$71.15 - $83.52 $25,685 - $30,150
361 Added 1.51%
24,341 $1.74 Million
Q3 2017

Oct 26, 2017
BUY
$72.11 - $85.47 $1.73 Million - $2.05 Million
23,980
23,980 $1.94 Million

Others Institutions Holding GILD

# of Institutions
2,366
Shares Held
1.01B
Call Options Held
8.63M
Put Options Held
7.39M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Benedict Financial Advisors Inc Portfolio

Follow Benedict Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email